Back to Authors

Johnston, Laura

A5053002300 | I4210137306

Mayo Clinic

Stanford Medicine

Citations 11

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Blood | July 1, 2014 | Volume: 124 | Issue: 8 | Pages: 1372-1377

10.1182/blood-2014-04-567164 | PMID 24982504

Key Points Tac/Sir prophylaxis provides equivalent GVHD-free survival when compared with Tac/Mtx in MRD transplantation. Tac/Sir is associated with more rapid engraftment and reduced oropharyngeal mucositis after MRD transplantation.